The series is stated in the current share scale after splits; dividends are not included in the price
Cencora distributes medicines to pharmacies and clinics — enormous turnover at a very thin margin, like all three distributors.
A distributor stands between manufacturer and dispensing point and earns fractions of a per cent per pack. At those margins profit is set by logistics: warehouses, routes, inventory turns and forecasting accuracy. An error anywhere consumes the entire margin.
The market is split among three players, which makes it durable: a new entrant cannot build a comparable warehouse network. The higher-margin line is servicing oncology and specialty clinics, where drugs are expensive and storage requirements strict.
A specific factor is opioid litigation settlements, with payments spread over years. Separately significant are high-cost medicines: the shipment value is large while the percentage is unchanged. The company pays a small dividend and buys back stock actively.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Cencora, Inc. (COR) is a company in the Health care sector; its shares trade on NYSE.
The price of Cencora, Inc. (COR) on November 2, 2026 is 335.85 $, +1.51 % on the day. Over 52 weeks the stock traded between 244.82 $ and 377.54 $; the price now sits 69 % of the way up that range. Over the past year the price changed by +6.82 %. The P/E ratio is 24.14, which is close to the sector median (24.61). Market capitalization is 63.36 billion $, rank 2 among 7 stocks of the same industry with a known capitalization.
Cencora, Inc. trades on NYSE under the ticker COR. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks COR has traded between 244.82 $ and 377.54 $. As of 2 November 2026 the price stood 72.78 % of the way from the 52-week low to the high.
Over one year COR shares rose 6.82 %; over six months they rose 5.91 %. Volatility over 90 days is 26.04 %. Dividends are not included: this is price change only, as of 2 November 2026.
COR trades at a price-to-earnings ratio of 24.1, below the sector median of 24.6. Price to sales is 0.2, below the sector median of 3.6. Price to book is 20.8, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Cencora, Inc. reported revenue of 332.8B $ and net income of 2.6B $ over the last four quarters. Net margin is 0.79 %. Revenue changed by +5.09 % year over year. Earnings per share are 13.47 $. Market capitalisation is 63.4B $.
COR has a return on equity of 86.03 %, above the sector median of −40.58 %. Return on assets is 3.13 %, above the sector median of −30.08 %. Operating margin is 0.91 %, above the sector median of −20.96 %.
